Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program.

Archive ouverte

Louet, Jean-Francois | Coste, Agnès | Amazit, Larbi | Tannour-Louet, Mounia | Wu, Ray-Chang | Tsai, Sophia y | Tsai, Ming-Jer | Auwerx, Johan | O'Malley, Bert W

Edité par CCSD ; National Academy of Sciences -

International audience. The white adipocyte is at the center of dysfunctional regulatory pathways in various pathophysiological processes, including obesity, diabetes, inflammation, and cancer. Here, we show that the oncogenic steroid receptor coactivator-3 (SRC-3) is a critical regulator of white adipocyte development. Indeed, in SRC-3(-/-) mouse embryonic fibroblasts, adipocyte differentiation was severely impaired, and reexpression of SRC-3 was able to restore it. The early stages of adipocyte differentiation are accompanied by an increase in nuclear levels of SRC-3, which accumulates to high levels specifically in the nucleus of differentiated fat cells. Moreover, SRC-3(-/-) animals showed reduced body weight and adipose tissue mass with a significant decrease of the expression of peroxisome proliferator-activated receptor gamma2 (PPARgamma2), a master gene required for adipogenesis. At the molecular level, SRC-3 acts synergistically with the transcription factor CAAT/enhancer-binding protein to control the gene expression of PPARgamma2. Collectively, these data suggest a crucial role for SRC-3 as an integrator of the complex transcriptional network controlling adipogenesis.

Consulter en ligne

Suggestions

Du même auteur

The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}.

Archive ouverte | Coste, Agnès | CCSD

International audience. Transcriptional control of metabolic circuits requires coordination between specific transcription factors and coregulators and is often deregulated in metabolic diseases. We characterized he...

Antidiabetic actions of estrogen: Insight from human and genetic mouse models

Archive ouverte | Le May, Cedric | CCSD

International audience

IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation.

Archive ouverte | Coste, Agnès | CCSD

We recently demonstrated that in vitro peroxisome proliferator-activated receptor-gamma (PPARgamma) activation of mouse peritoneal macrophages by IL-13 or PPARgamma ligands promotes uptake and killing of Candida albicans through m...

Chargement des enrichissements...